These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2675496)

  • 1. [Magnesium--a new therapeutic alternative in primary dysmenorrhea].
    Seifert B; Wagler P; Dartsch S; Schmidt U; Nieder J
    Zentralbl Gynakol; 1989; 111(11):755-60. PubMed ID: 2675496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effects of magnesium in dysmenorrhea].
    Fontana-Klaiber H; Hogg B
    Schweiz Rundsch Med Prax; 1990 Apr; 79(16):491-4. PubMed ID: 2349410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors.
    Dreher E; von Fischer B
    Adv Prostaglandin Thromboxane Res; 1980; 8():1487-93. PubMed ID: 6769316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
    Chan WY; Fuchs F; Powell AM
    Obstet Gynecol; 1983 Mar; 61(3):285-91. PubMed ID: 6571974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea.
    Nigam S; Benedetto C; Zonca M; Leo-Rossberg I; Lübbert H; Hammerstein J
    Eicosanoids; 1991; 4(3):137-41. PubMed ID: 1772686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Symptomatic therapy of primary dysmonorrhea by inhibition of prostaglandin synthesis with indomethacin (author's transl)].
    Cornely M; Beutnagel H; Schönhöfer PS
    Geburtshilfe Frauenheilkd; 1978 Jan; 38(1):18-24. PubMed ID: 627337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapy of dysmenorrhea].
    Zahradnik HP; Breckwoldt M
    Gynakologe; 1988 Mar; 21(1):58-62. PubMed ID: 2897319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of ketoprofen and mefenamic acid in the treatment of primary dysmenorrhea.
    Hébert JG; Le Morvan P; Bourgouin J
    Clin Ther; 1986; 8(3):329-35. PubMed ID: 3521860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of primary prostaglandin (Pgs) and main metabolite of PgF2 alpha in blood plasma for diagnosis of primary dysmenorrhoea].
    Seifert B; Liedtke MP
    Zentralbl Gynakol; 1982; 104(10):577-83. PubMed ID: 6957086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary dysmenorrhoea treated with indomethacin].
    Hamann GO; Laursen B
    Ugeskr Laeger; 1977 Aug; 139(32):1899-1901. PubMed ID: 333681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of danggui shaoyao powder on blood rheological indexes and prostaglandin F2 alpha in dysmenorrhea patients].
    Xie C
    Zhong Xi Yi Jie He Za Zhi; 1990 Jul; 10(7):410-2, 389. PubMed ID: 2208420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ketoprofen in treating primary dysmenorrhea.
    Gleeson S; Sorbie J
    Can Med Assoc J; 1983 Oct; 129(8):842-4. PubMed ID: 6351994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of fenoprofen in the treatment of primary dysmenorrhea.
    Osathanondh R; Caldwell BV; Kaul AF; Sokoloff BJ; White RM; Scavone JM; Burt RA; Naftolin F
    J Reprod Med; 1985 Dec; 30(12):915-9. PubMed ID: 3908675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of progesterone uterine therapeutic system on dysmenorrhoea: prostaglandin F2alpha levels in menstrual blood (author's transl)].
    Zahradnik HP; Stengele E; Kraut E; Scharpf G; Breckwoldt M
    Dtsch Med Wochenschr; 1978 Aug; 103(32):1270-3. PubMed ID: 668582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirprofen, naproxen and placebo in the treatment of primary dysmenorrhoea.
    Marchini M; Fedele L; Garagiola U; Maresca V
    Drugs Exp Clin Res; 1987; 13(11):699-705. PubMed ID: 3327669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents.
    Harel Z; Riggs S; Vaz R; Flanagan P; Harel D
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):183-6. PubMed ID: 15125904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of action of dydrogesterone in dysmehorrhea. Prostaglandin levels in menstrual blood].
    Zahradnik HP
    Fortschr Med; 1984 Apr; 102(15):439-42. PubMed ID: 6724478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of flurbiprofen and paracetamol in the treatment of primary dysmenorrhoea.
    Maclean D
    J Int Med Res; 1983; 11 Suppl 2():1-5. PubMed ID: 6409690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uterine prostaglandins and dysmenorrhea].
    Seifert B; Liedtke MP
    Zentralbl Gynakol; 1978; 100(21):1361-6. PubMed ID: 735539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.